HHS greenlights sale of six unapproved peptides despite FDA guidance
The move followed an early vote to relax regulations against the guidance of FDA
DO
By Daniel Okafor · Regulatory Correspondent
Nov 4 10:26 ETSource: BioXconomy
From the source
Read at bioxconomy.comHHS greenlights sale of six unapproved peptides despite FDA guidance
The move followed an early vote to relax regulations against the guidance of FDA experts.
